Zhejiang Wecome Pharmaceutical Company Limited

SZSE:300878.SZ

23.26 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 260.16253.961324.273320.582226.179330.162195.806440.148212.934162.741192.701204.37193.666280.796318.609369.393486.497595.228818.855140.517-160.885160.885-83.226
Short Term Investments 50250-13.194245.565241-11.596-11.06700015.433-12.738-13.492-14.066-14.299-14.57600321.770166.452
Cash and Short Term Investments 265.16253.961324.273320.582226.179575.727436.806440.148212.934162.741192.701204.37193.666280.796318.609369.393486.497595.228818.855140.517160.885160.88583.226
Net Receivables 182.118217.868326.883294.408337.291294.747341.116335.8357.397333.887428.391448.187462.283409.896430.015377.65306.741299.676308.053270.7150209.7360
Inventory 137.16118.325109.062135.218123.351153.785158.872137.099121.774116.78201.2111.924125.139129.49299.78495.21689.57482.30660.0363.785060.4590
Other Current Assets 26.35626.32828.24233.66320.53610.50145.76233.751278.254420.58670.98256.97454.84349.90288.485.43362.38821.40619.6219.0209.8610
Total Current Assets 610.794616.482788.46783.871707.3571,034.76982.556946.797970.3591,033.994893.274821.456835.931870.086936.808927.692945.2998.6161,206.558494.037160.885440.94283.226
Non-Current Assets:
Property, Plant & Equipment, Net 853.604853.663917.165926.237874.282859.257989.577964.331928.106761.5831.873781.287754.629706.095644.219602.651584.143548.955456.262410.7920368.9430
Goodwill 10.94210.96517.18127.03627.04927.08427.09627.15327.18827.22217.43117.49417.55717.6216.40400000000
Intangible Assets 33.14733.59233.92735.135.19835.66736.16436.64237.10437.56238.03938.4538.88639.30639.82335.18135.530.06530.27730.41030.7130
Goodwill and Intangible Assets 44.08844.55751.10862.13662.24762.75163.2663.79564.29164.78455.4755.94456.44356.92656.22735.18135.530.06530.27730.41030.7130
Long Term Investments 200033.33339.749-219.012-21636.59636.067255.6060032.70233.45634.0334.26334.548.7419.674011.490
Tax Assets 47.22954.66531.21428.8542627.0712.49514.16618.635011.8722.85622.96324.5945.9197.1156.1846.1175.7825.5604.9320
Other Non-Current Assets 62.93482.95547.0973.99928.359281.811252.7560.8130.9529.2546.63412.90728.92.9057.3910.097.3910.48919.41219.412-160.88518.848-83.226
Total Non-Current Assets 1,027.8561,035.8411,046.5851,054.5591,030.6381,011.8771,102.0881,079.7011,048.048880.538911.454872.994862.936823.222747.212689.068667.481630.166520.475475.849-160.885434.926-83.226
Total Assets 1,638.651,652.3231,835.0451,838.431,737.9952,046.6372,084.6442,026.4982,018.4071,914.5331,804.7281,694.451,698.8671,693.3081,684.0191,616.761,612.6811,628.7821,727.033969.8860875.8680
Liabilities & Equity:
Current Liabilities:
Account Payables 87.0178.85447.02531.23270.492101.11691.674.63478.16795.752184.60180.566102.33333.92174.22296.34524.065114.99783.95475.927074.9380
Short Term Debt 010.00960.0160.160.15261.904300.539259.497318.738269.00380.078100.0555196.626129.1970062.48314.71214.712028.5420
Tax Payables 14.22420.356.0980.6637.0745.4382.0393.266.43301.8368.0635.61411.423.53122.0524.69218.72418.29431.455024.3490
Deferred Revenue 00014.64946.35355.82132.68326.95932.436032.6540.27858.0271.595115.2574.4368.50882.61491.13998.983080.4890
Other Current Liabilities 126.858131.16939.53483.8484.9346.95117.23646.62839.32848.31333.18937.72265.14128.63386.81386.183127.62160.86569.5-30.838061.8440
Total Current Liabilities 228.092240.382152.667175.902129.002431.23426.825392.463452.93413.067307.358231.514224.087232.401240.213204.579164.886213.65190.312190.2390189.6730
Non-Current Liabilities:
Long Term Debt 201.686191.798277.475283.806182.545163.131130.723114.32285.32650.09914.70216.90719.81119.99110.48310.96912.3080172.052171.9450136.3870
Deferred Revenue Non-Current 37.86138.92339.98440.96741.92542.83336.06236.9734.881023.99824.41724.73625.00525.27425.54325.81326.08226.35126.62027.1580
Deferred Tax Liabilities Non-Current 7.3727.3960.8832.1111.8822.0336.2246.286.31507.1847.2476.8246.8875.4195.1674.9144.6623.583.19302.8070
Other Non-Current Liabilities 00000000040.323000000026.08200000
Total Non-Current Liabilities 246.919238.116318.342285.917226.352207.998173.008157.571126.52290.42245.88348.57151.37151.88341.17641.67943.03530.744201.984201.7580166.3520
Total Liabilities 475.011478.498471.009461.819355.354639.228599.833550.035579.452503.489353.241280.085275.458284.283281.389246.258207.921244.394392.296391.9980356.0250
Equity:
Preferred Stock 00000000000000000000000
Common Stock 144.79144.79144.79144.79144.79144.79144.79144.79144.79144.79144.79144.7980.43980.43980.43980.43980.43980.43980.43960.329060.3290
Retained Earnings 307.057316.912507.823477.917523.407499.238581.123576.393539.298572.291563.194526.249535.62512.7509.073479.976516.916496.644464.156432.9030374.8590
Accumulated Other Comprehensive Income/Loss 00065.015-0-0741.75660.991741.756-0739.82159.056804.17259.056804.17259.056804.172000519.843-0393.831
Other Total Stockholders Equity 695.964695.964695.784695.784695.781745.780741.7560680.7650739.8210804.1720804.1720804.172039.631084.6560
Total Shareholders Equity 1,147.8121,157.6671,348.3971,318.4921,363.9781,389.8081,467.6691,462.9391,425.8441,397.8461,447.8051,410.861,420.2311,397.3111,393.6841,364.5871,401.5271,381.2551,334.737577.888519.843519.843393.831
Total Equity 1,163.6391,173.8251,364.0351,335.6441,382.6411,407.4091,484.8111,476.4631,438.9561,411.0431,451.4871,414.3651,423.4091,409.0251,402.631,370.5021,404.761,384.3881,334.737577.888519.843519.843393.831
Total Liabilities & Shareholders Equity 1,638.651,652.3231,835.0451,838.431,737.9952,046.6372,084.6442,026.4982,018.4071,914.5331,804.7281,694.451,698.8671,693.3081,684.0191,616.761,612.6811,628.7821,727.033969.886519.843875.868393.831